Authors: COLIN P GANEM G WENDLING J NOURYGAT P KIRSCHER S AMALRIC F COSCAS Y FACCHINI T SERIN D

Citation: P. Colin et al., OUTPATIENT ADJUVANT HIGH-DOSE DENSITY CHEMOTHERAPY (HDDC) WITHOUT HEMATOPOIETIC RESCUE FOR POOR-PROGNOSIS BREAST-CANCER - A GERCOR STUDY, Annals of oncology, 9, 1998, pp. 38-38

Authors: FACCHINI T GENET D BERDAH JF NOUYRIGAT P DUTIN JP LAPLAIGE P SMITH M FANDI A

Citation: T. Facchini et al., RALTITREXED (TOMUDEX(R)) TREATMENT FOR ELDERLY PATIENTS WITH METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY TOXICITY REPORT, Annals of oncology, 9, 1998, pp. 195-195

Authors: SPAETH D BONNETERRE J MARTY M KHAYAT D FACCHINI T CONROY T

Citation: D. Spaeth et al., PHASE-II STUDIES OF 2 TRIAL REGIMENS OF TOPOTECAN AS 2ND-LINE SINGLE-AGENT THERAPY IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 704-704

Authors: FACCHINI T BELPOMME D KEMP G ROSE P ROULLET B PHILLIPS P SCHEFFLER BJ OSTER W CAPIZZI RL SCHEIN PS

Citation: T. Facchini et al., AMIFOSTINE (AMI) SELECTIVELY PROTECTS AGAINST CUMULATIVE TOXICITIES OF CYCLOPHOSPHAMIDE (C) AND CISPLATIN (P), European journal of cancer, 31A, 1995, pp. 500-500

Authors: COLLIN GP CUNY JF CHEVELLE C FACCHINI T

Citation: Gp. Collin et al., PSEUDOMONAS-AERUGINOSA AND ECTHYMA GANGRE NOSUM - REPORT OF A CASE WITH A REVIEW OF THE LITERATURE, La Semaine des hopitaux de Paris, 70(7-8), 1994, pp. 228-232